The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis) Meeting Abstract

  

Authors:	Tully, C. M.; Apolo, A. B.; Zabor, E. C.; Regazzi, A. M.; Ostrovnaya, I.; Rosenberg, J. E.; Bajorin, D. F.
Abstract Title:	The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis)
Meeting Title:	2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	4 Suppl.
Meeting Dates:	2014 Jan 30-Feb 1
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-02-01
Language:	English
ACCESSION:	WOS:000335318100317
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.4_suppl.316
Notes:	Meeting Abstract: 316 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/52576